These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 10846597)
1. The role of resistance testing in clinical trial design and product labelling: a regulatory perspective. Laessig KA; Murray JS; Chikami G Antivir Ther; 2000 Mar; 5(1):77-83. PubMed ID: 10846597 [TBL] [Abstract][Full Text] [Related]
2. Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy. Hanna GJ; D'Aquila RT Clin Infect Dis; 2001 Mar; 32(5):774-82. PubMed ID: 11229846 [TBL] [Abstract][Full Text] [Related]
4. Clinical utility of testing human immunodeficiency virus for drug resistance. Harrigan PR; Côté HC Clin Infect Dis; 2000 Jun; 30 Suppl 2():S117-22. PubMed ID: 10860895 [TBL] [Abstract][Full Text] [Related]
6. Principles of HIV resistance testing and overview of assay performance characteristics. Richman DD Antivir Ther; 2000 Mar; 5(1):27-31. PubMed ID: 10846590 [TBL] [Abstract][Full Text] [Related]
7. Genotypic resistance tests for the clinical management of patients with primary HIV infection. Narciso P; Lazzarin A Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588 [TBL] [Abstract][Full Text] [Related]
8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
9. HIV drug resistance testing: is the evidence really there? Dunn DT; Gibb DM; Babiker AG; Green H; Darbyshire JH; Weller IV Antivir Ther; 2004 Oct; 9(5):641-8. PubMed ID: 15535402 [TBL] [Abstract][Full Text] [Related]
10. [Drug resistance in antiretroviral therapy of HIV infection]. Oette M; Häussinger D Med Klin (Munich); 2003 Dec; 98(12):692-9. PubMed ID: 14685670 [TBL] [Abstract][Full Text] [Related]
12. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice. Haupts S; Ledergerber B; Böni J; Schüpbach J; Kronenberg A; Opravil M; Flepp M; Speck RF; Grube C; Rentsch K; Weber R; Günthard HF; Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392 [TBL] [Abstract][Full Text] [Related]
13. Updated European recommendations for the clinical use of HIV drug resistance testing. Vandamme AM; Sönnerborg A; Ait-Khaled M; Albert J; Asjo B; Bacheler L; Banhegyi D; Boucher C; Brun-Vézinet F; Camacho R; Clevenbergh P; Clumeck N; Dedes N; De Luca A; Doerr HW; Faudon JL; Gatti G; Gerstoft J; Hall WW; Hatzakis A; Hellmann N; Horban A; Lundgren JD; Kempf D; Miller M; Miller V; Myers TW; Nielsen C; Opravil M; Palmisano L; Perno CF; Phillips A; Pillay D; Pumarola T; Ruiz L; Salminen M; Schapiro J; Schmidt B; Schmit JC; Schuurman R; Shulse E; Soriano V; Staszewski S; Vella S; Youle M; Ziermann R; Perrin L Antivir Ther; 2004 Dec; 9(6):829-48. PubMed ID: 15651743 [TBL] [Abstract][Full Text] [Related]
14. The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. Weinstock HS; Zaidi I; Heneine W; Bennett D; Garcia-Lerma JG; Douglas JM; LaLota M; Dickinson G; Schwarcz S; Torian L; Wendell D; Paul S; Goza GA; Ruiz J; Boyett B; Kaplan JE J Infect Dis; 2004 Jun; 189(12):2174-80. PubMed ID: 15181563 [TBL] [Abstract][Full Text] [Related]
15. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Hirsch MS; Günthard HF; Schapiro JM; Brun-Vézinet F; Clotet B; Hammer SM; Johnson VA; Kuritzkes DR; Mellors JW; Pillay D; Yeni PG; Jacobsen DM; Richman DD Clin Infect Dis; 2008 Jul; 47(2):266-85. PubMed ID: 18549313 [TBL] [Abstract][Full Text] [Related]
16. Current insights into reverse transcriptase inhibitor-associated resistance. Wainberg MA; White AJ Antivir Ther; 2001; 6 Suppl 2():11-9. PubMed ID: 11678474 [No Abstract] [Full Text] [Related]
17. Primary drug resistance in antiretroviral-naïve injection drug users. Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493 [TBL] [Abstract][Full Text] [Related]
18. [The impact of resistance testing of HIV-1 to the HIV clinical setting in Japan]. Yamamoto Y Nihon Rinsho; 2002 Apr; 60(4):769-74. PubMed ID: 11968786 [TBL] [Abstract][Full Text] [Related]